{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T19:09:31Z","timestamp":1774638571988,"version":"3.50.1"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T00:00:00Z","timestamp":1551398400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T00:00:00Z","timestamp":1551398400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Critical Reviews in Oncology\/Hematology"],"published-print":{"date-parts":[[2019,3]]},"DOI":"10.1016\/j.critrevonc.2019.01.019","type":"journal-article","created":{"date-parts":[[2019,1,31]],"date-time":"2019-01-31T21:35:27Z","timestamp":1548970527000},"page":"59-65","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":34,"special_numbering":"C","title":["Effect of neoadjuvant chemotherapy on locally advanced upper tract urothelial carcinoma: A systematic review and meta-analysis"],"prefix":"10.1016","volume":"135","author":[{"given":"Do Kyung","family":"Kim","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joo Yong","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jong Won","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6424-4619","authenticated-orcid":false,"given":"Yoon Soo","family":"Hah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3500-8833","authenticated-orcid":false,"given":"Kang Su","family":"Cho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.critrevonc.2019.01.019_bib0005","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.urolonc.2010.07.016","article-title":"The role of chemotherapy in the treatment of urothelial cell carcinoma of the upper urinary tract (UUT-UCC)","volume":"31","author":"Audenet","year":"2013","journal-title":"Urol. Oncol."},{"key":"10.1016\/j.critrevonc.2019.01.019_bib0010","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.eururo.2005.04.006","article-title":"Neoadjuvant chemotherapy in invasive bladder cancer: update of a systematic review and meta-analysis of individual patient data advanced bladder cancer (ABC) meta-analysis collaboration","volume":"48","author":"C. V","year":"2005","journal-title":"Eur. Urol."},{"key":"10.1016\/j.critrevonc.2019.01.019_bib0015","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.cct.2006.04.004","article-title":"Random-effects model for meta-analysis of clinical trials: an update","volume":"28","author":"DerSimonian","year":"2007","journal-title":"Contemp. Clin. Trials"},{"key":"10.1016\/j.critrevonc.2019.01.019_bib0020","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.critrevonc.2018.05.005","article-title":"Perioperative chemotherapy for urothelial carcinoma of the upper urinary tract: a systematic review and meta-analysis","volume":"128","author":"Gregg","year":"2018","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"10.1016\/j.critrevonc.2019.01.019_bib0025","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1136\/bmj.39489.470347.AD","article-title":"GRADE: an emerging consensus on rating quality of evidence and strength of recommendations","volume":"336","author":"Guyatt","year":"2008","journal-title":"BMJ (Clin. Res. Ed)"},{"key":"10.1016\/j.critrevonc.2019.01.019_bib0030","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1136\/bmj.39490.551019.BE","article-title":"What is \"quality of evidence\" and why is it important to clinicians?","volume":"336","author":"Guyatt","year":"2008","journal-title":"BMJ (Clin. Res. Ed)"},{"key":"10.1016\/j.critrevonc.2019.01.019_bib0035","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ (Clin. Res. Ed)"},{"key":"10.1016\/j.critrevonc.2019.01.019_bib0040","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1016\/j.euf.2017.03.013","article-title":"Platinum-based neoadjuvant chemotherapy improves oncological outcomes in patients with locally advanced upper tract urothelial carcinoma","volume":"4","author":"Hosogoe","year":"2018","journal-title":"Eur. Urol. Focus"},{"key":"10.1016\/j.critrevonc.2019.01.019_bib0045","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1159\/000282755","article-title":"Neoadjuvant chemotherapy for locally advanced urothelial cancer of the upper urinary tract","volume":"55","author":"Igawa","year":"1995","journal-title":"Urol. Int."},{"key":"10.1016\/j.critrevonc.2019.01.019_bib0050","doi-asserted-by":"crossref","first-page":"375","DOI":"10.3349\/ymj.2015.56.2.375","article-title":"The characteristics of recurrent upper tract urothelial carcinoma after radical nephroureterectomy without bladder cuff excision","volume":"56","author":"Kang","year":"2015","journal-title":"Yonsei Med. J."},{"key":"10.1016\/j.critrevonc.2019.01.019_bib0055","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1093\/jjco\/hys166","article-title":"A role for preoperative systemic chemotherapy in node-positive upper tract urothelial carcinoma treated with radical nephroureterectomy","volume":"42","author":"Kitamura","year":"2012","journal-title":"Jpn. J. Clin. Oncol."},{"key":"10.1016\/j.critrevonc.2019.01.019_bib0060","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1111\/iju.13010","article-title":"Effect of preoperative chemotherapy on survival of patients with upper urinary tract urothelial carcinoma clinically involving regional lymph nodes","volume":"23","author":"Kobayashi","year":"2016","journal-title":"Int. J. Urol."},{"key":"10.1016\/j.critrevonc.2019.01.019_bib0065","doi-asserted-by":"crossref","first-page":"101500","DOI":"10.18632\/oncotarget.21551","article-title":"Oncological outcomes of neoadjuvant chemotherapy in patients with locally advanced upper tract urothelial carcinoma: a multicenter study","volume":"8","author":"Kubota","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.critrevonc.2019.01.019_bib0070","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.eururo.2014.03.003","article-title":"A systematic review and meta-analysis of adjuvant and neoadjuvant chemotherapy for upper tract urothelial carcinoma","volume":"66","author":"Leow","year":"2014","journal-title":"Eur. Urol."},{"key":"10.1016\/j.critrevonc.2019.01.019_bib0075","doi-asserted-by":"crossref","first-page":"e000126","DOI":"10.1136\/esmoopen-2016-000126","article-title":"Upper tract urothelial carcinoma: a different disease entity in terms of management","volume":"1","author":"Leow","year":"2016","journal-title":"ESMO Open"},{"key":"10.1016\/j.critrevonc.2019.01.019_bib0080","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1111\/bju.12801","article-title":"The role of adjuvant chemotherapy for lymph node-positive upper tract urothelial carcinoma following radical nephroureterectomy: a retrospective study","volume":"116","author":"Lucca","year":"2015","journal-title":"BJU Int."},{"key":"10.1016\/j.critrevonc.2019.01.019_bib0085","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1002\/cncr.24135","article-title":"Outcomes of radical nephroureterectomy: a series from the upper tract urothelial carcinoma collaboration","volume":"115","author":"Margulis","year":"2009","journal-title":"Cancer"},{"key":"10.1016\/j.critrevonc.2019.01.019_bib0090","doi-asserted-by":"crossref","first-page":"3127","DOI":"10.1002\/cncr.25050","article-title":"Incidence of downstaging and complete remission after neoadjuvant chemotherapy for high-risk upper tract transitional cell carcinoma","volume":"116","author":"Matin","year":"2010","journal-title":"Cancer"},{"issue":"4","key":"10.1016\/j.critrevonc.2019.01.019_bib0095","article-title":"Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement","author":"Moher","year":"2015","journal-title":"Syst. Rev."},{"key":"10.1016\/j.critrevonc.2019.01.019_bib0100","doi-asserted-by":"crossref","DOI":"10.1155\/2009\/419028","article-title":"The role of chemotherapy in upper tract urothelial carcinoma","author":"O\u2019Donnell","year":"2009","journal-title":"Adv. Urol."},{"key":"10.1016\/j.critrevonc.2019.01.019_bib0105","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.eururo.2004.04.011","article-title":"EAU guidelines on diagnosis and treatment of upper urinary tract transitional cell carcinoma","volume":"46","author":"Oosterlinck","year":"2004","journal-title":"Eur. Urol."},{"key":"10.1016\/j.critrevonc.2019.01.019_bib0110","doi-asserted-by":"crossref","first-page":"2815","DOI":"10.1002\/(SICI)1097-0258(19981230)17:24<2815::AID-SIM110>3.0.CO;2-8","article-title":"Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints","volume":"17","author":"Parmar","year":"1998","journal-title":"Stat. Med."},{"key":"10.1016\/j.critrevonc.2019.01.019_bib0115","doi-asserted-by":"crossref","first-page":"1794","DOI":"10.1002\/cncr.28655","article-title":"Neoadjuvant chemotherapy improves survival of patients with upper tract urothelial carcinoma","volume":"120","author":"Porten","year":"2014","journal-title":"Cancer"},{"key":"10.1016\/j.critrevonc.2019.01.019_bib0120","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1038\/ncpuro0875","article-title":"Management of patients with upper urinary tract transitional cell carcinoma","volume":"4","author":"Raman","year":"2007","journal-title":"Nat. Clin. Pract. Urol."},{"issue":"73","key":"10.1016\/j.critrevonc.2019.01.019_bib0125","first-page":"111","article-title":"European association of urology guidelines on upper urinary tract urothelial carcinoma","volume":"2018","author":"Roupret","year":"2017","journal-title":"Eur. Urol."},{"key":"10.1016\/j.critrevonc.2019.01.019_bib0130","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1002\/cncr.27751","article-title":"A phase 2 clinical trial of sequential neoadjuvant chemotherapy with ifosfamide, doxorubicin, and gemcitabine followed by cisplatin, gemcitabine, and ifosfamide in locally advanced urothelial cancer: final results","volume":"119","author":"Siefker-Radtke","year":"2013","journal-title":"Cancer"},{"key":"10.1016\/j.critrevonc.2019.01.019_bib0135","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.6004\/jnccn.2017.0156","article-title":"Bladder Cancer, Version 5.2017, NCCN Clinical Practice Guidelines in Oncology","volume":"15","author":"Spiess","year":"2017","journal-title":"J. Natl. Compr. Cancer Netw.: JNCCN"},{"key":"10.1016\/j.critrevonc.2019.01.019_bib0140","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.ucl.2017.12.002","article-title":"Optimal timing of chemotherapy and surgery in patients with muscle-invasive bladder cancer and upper urinary tract urothelial carcinoma","volume":"45","author":"Tabayoyong","year":"2018","journal-title":"Urol. Clin. North Am."},{"key":"10.1016\/j.critrevonc.2019.01.019_bib0145","series-title":"The Newcastle\u2013Ottawa Scale (NOS) for Assessing the Quality of Non-Randomized Studies in Meta-Analysis","author":"Wells","year":"2012"},{"key":"10.1016\/j.critrevonc.2019.01.019_bib0150","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1111\/j.1464-410X.2012.11649.x","article-title":"Impact of renal function on eligibility for chemotherapy and survival in patients who have undergone radical nephro-ureterectomy","volume":"112","author":"Xylinas","year":"2013","journal-title":"BJU Int."},{"key":"10.1016\/j.critrevonc.2019.01.019_bib0155","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1002\/1097-0142(19870801)60:3+<574::AID-CNCR2820601524>3.0.CO;2-C","article-title":"Chemotherapy of urothelial tract tumors","volume":"60","author":"Yagoda","year":"1987","journal-title":"Cancer"},{"key":"10.1016\/j.critrevonc.2019.01.019_bib0160","doi-asserted-by":"crossref","first-page":"3568","DOI":"10.18632\/oncotarget.12239","article-title":"Perioperative treatments for resected upper tract urothelial carcinoma: a network meta-analysis","volume":"8","author":"Yang","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.critrevonc.2019.01.019_bib0165","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1111\/j.1464-410X.2011.10075.x","article-title":"Upper urinary tract urothelial carcinoma with loco-regional nodal metastases: insights from the Upper Tract Urothelial Carcinoma Collaboration","volume":"108","author":"Youssef","year":"2011","journal-title":"BJU Int."},{"key":"10.1016\/j.critrevonc.2019.01.019_bib0170","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1016\/j.eururo.2008.01.006","article-title":"Urothelial carcinoma of the upper urinary tract: surgical approach and prognostic factors","volume":"53","author":"Zigeuner","year":"2008","journal-title":"Eur. Urol."}],"container-title":["Critical Reviews in Oncology\/Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1040842818304906?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1040842818304906?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T19:28:36Z","timestamp":1760902116000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1040842818304906"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3]]},"references-count":34,"alternative-id":["S1040842818304906"],"URL":"https:\/\/doi.org\/10.1016\/j.critrevonc.2019.01.019","relation":{},"ISSN":["1040-8428"],"issn-type":[{"value":"1040-8428","type":"print"}],"subject":[],"published":{"date-parts":[[2019,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effect of neoadjuvant chemotherapy on locally advanced upper tract urothelial carcinoma: A systematic review and meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Critical Reviews in Oncology\/Hematology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.critrevonc.2019.01.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}